Skip to main content
. 2017 Apr 20;12:73. doi: 10.1186/s13023-017-0624-2

Fig. 4.

Fig. 4

Reduced Rieske iron-sulfur protein (RISP) immunoreactivity in patient brain. a Immunostaining for RISP in the occipital cortex of control and (b) patient brain. Cytoplasmic localization of RISP in cortical neuronal cells in control (c) and reduced amount of RISP immunoreactivity in the patient brain (d). Scale bars 100 μm